Bacteria engineered to treat diseases associated with hyperammonemia
US9688967B2 · kind B2 · utility
26Cited by
5References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 25, 2016 |
| Grant date | Jun 27, 2017 |
| Priority date | — |
| Expiry date | May 25, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12R2001/19
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of modulating and treating disorders associated with hyperammonemia are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.